Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies
Posted:
Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.
The GIANT Health Event 2026 will close its second day with a free Christmas Party on Tuesday 8 December, from 3:00 p.m. to 6:00 p.m., at the Business Design Centre in London.
GIANT Health (Global Innovation and New Technology) is…
Cardiovascular disease remains one of the leading causes of illness and death worldwide, placing significant pressure on healthcare systems and highlighting the importance of early diagnosis and timely intervention. As digital health technologies continue to evolve, wearable devices and artificial…
Attendees
Sponsors and Exhibitors
Contact us